Researchers at the University of Southampton have engineered cells with a ‘built-in genetic circuit’ that produces a molecule that inhibits the ability of tumours to survive and grow in their low oxygen environment.
The genetic circuit produces the machinery necessary for the production of a compound that inhibits a protein which has a significant and critical role in the growth and survival of cancer cells. This results in the cancer cells being unable to survive in the low oxygen, low nutrient tumour micro-environment.
As tumours develop and grow, they rapidly outstrip the supply of oxygen delivered by existing blood vessels. This results in cancer cells needing to adapt to low oxygen environment.
To enable them to survive, adapt and grow in the low-oxygen or ‘hypoxic’ environments, tumours contain increased levels of a protein called Hypoxia-inducible factor 1 (HIF-1). HIF-1 senses reduced oxygen levels and triggers many changes in cellular function, including a changed metabolism and sending signals for the formation of new blood vessels. It is thought that tumours primarily hijack the function of this protein (HIF-1) to survival and grow.
Professor Ali Tavassoli, who led the study with colleague Dr. Ishna Mistry, explains: “In an effort to better understand the role of HIF-1 in cancer, and to demonstrate the potential for inhibiting this protein in cancer therapy, we engineered a human cell line with an additional genetic circuit that produces the HIF-1 inhibiting molecule when placed in a hypoxic environment.
“We’ve been able to show that the engineered cells produce the HIF-1 inhibitor, and this molecule goes on to inhibit HIF-1 function in cells, limiting the ability of these cells to survive and grow in a nutrient-limited environment as expected.
“In a wider sense, we have given these engineered cells the ability to fight back – to stop a key protein from functioning in cancer cells. This opens up the possibility for the production and use of sentinel circuits, which produce other bioactive compounds in response to environmental or cellular changes, to target a range of diseases including cancer.”
The genetic circuit is incorporated onto the chromosome of a human cell line, which encodes the protein machinery required for the production of their cyclic peptide HIF-1 inhibitor. The production of the HIF-1 inhibitor occurs in response to hypoxia in these cells. The research team demonstrated that even when produced directly in cells, this molecule still prevents the HIF-1 signalling and the associated adaptation to hypoxia in these cells.
The next step for the researchers is to demonstrate the viability of this approach to the production and delivery of an anticancer molecule in a whole tumour model system.
Professor Tavassoli adds: “The main application for this work is that it eliminates the need for the synthesis of our inhibitor, so that biologists conducting research into HIF function can easily access our molecule and hopefully discover more about the role of HIF-1 in cancer. This will also let us understand whether inhibiting HIF-1 function alone is enough to block cancer growth in relevant models. Another interesting aspect to the work is that it demonstrates the possibility of adding new machinery to human cells to enable them to make therapeutic agents in response to disease signals.”
Learn more: Human cells with a ‘built-in circuit’ help prevent tumour growth
The Latest on: Built-in genetic circuit
[google_news title=”” keyword=”built-in genetic circuit” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Built-in genetic circuit
- Neural circuits revealed as key regulators in body's immune response, study findson May 6, 2024 at 10:18 pm
A recent study in Nature reveals how specific neural circuits within the body-brain axis regulate immune responses, highlighting potential new therapeutic approaches for immune disorders.
- Research team develops fast-track process for genetic improvement of plant traitson May 6, 2024 at 12:10 pm
Researchers interested in improving a given trait in plants can now identify the genes that regulate the trait's expression without doing any experiments.
- Ethical Issues in Genetic Testingon May 4, 2024 at 5:00 pm
The Committee on Assessing Genetic Risks, Division of Health Sciences Policy, Institute of Medicine, emphasizes autonomy, confidentiality, privacy, and equity (justice) as being foundational for ...
- Ethical Issues in Genetic Testingon May 3, 2024 at 5:01 pm
Discussions about ethics are important in many aspects of health care but are especially critical when the health care includes genetic testing. There are several aspects of genetic testing that ...
- Genetic Counselor Salaryon April 29, 2024 at 5:00 pm
How Much Does a Genetic Counselor Make? Genetic Counselors made a median salary of $89,990 in 2022. The best-paid 25% made $104,610 that year, while the lowest-paid 25% made $79,940. The ...
- Social change may explain decline in genetic diversity of the Y chromosome at the end of the Neolithic periodon April 24, 2024 at 2:01 am
The emergence in the Neolithic of patrilineal 1 social systems, in which children are affiliated with their father's lineage, may explain a spectacular decline in the genetic diversity of the Y ...
- Great Lakes Circuit in Gear for 2024on April 19, 2024 at 4:59 pm
The Great Lakes Circuit is one of 12 PRCA circuits in the country. Nine northern states make up the circuit: Minnesota, Iowa, Wisconsin, Missouri, Illinois, Kentucky, Michigan, Ohio, and Indiana.
- North Korea ‘using genetic engineering in biological weapons programme’on April 16, 2024 at 11:42 pm
North Korea is genetically engineering the ingredients for biological armaments to produce bacteria, viruses and toxins as part of a germ warfare programme, the United States has said in its ...
- From a cryptic genetic element in the human gut to a sensitive biomarkeron April 15, 2024 at 5:00 pm
Plasmids are small extrachromosomal genetic elements that frequently occur in bacterial cells and can influence microbial lifestyles – yet their diversity in natural habitats is poorly understood.
via Bing News